Literature DB >> 25498050

Contrast-enhanced ultrasonography in the early period after kidney transplantation predicts long-term allograft function.

V Schwenger1, V Hankel2, J Seckinger1, S Macher-Göppinger3, C Morath1, M Zeisbrich1, M Zeier1, L P Kihm4.   

Abstract

INTRODUCTION: Real-time contrast-enhanced sonography (CES) can assess microvascular tissue perfusion using gas-filled microbubbles. The purpose of the study was to evaluate the feasibility of early CES in predicting long-term kidney allograft function in comparison to color Doppler ultrasonography (CDUS).
METHODS: We prospectively studied 68 consecutive kidney transplant recipients using CES and conventional CDUS investigation 1 week after transplantation. Transplant tissue perfusion imaging was performed by low-power imaging during intravenous administration of the sonocontrast SonoVue. Renal tissue perfusion was assessed quantitatively using flash replenishment kinetics of microbubbles to estimate renal blood flow (RBF). The obtained sonography values were correlated with clinical data 1 week up to 1 year after transplantation.
RESULTS: In contrast with conventional CDUS resistive indices, RBF estimated by CES 1 week posttransplantation significantly correlated with kidney function after 1 year (r = 0.67; P < .001). Determination of RBF by CES revealed a significant correlation with donor age but not recipient age, whereas conventional CDUS resistive index was significantly correlated to recipient age (r = 0.54; P < .001) but not donor age. Furthermore RBF was associated with vascular fibrosis and intimal thickening of the engraftment biopsies.
CONCLUSION: This is the first prospective study demonstrating the prognostic value of CES early after kidney transplantation. In contrast with CDUS, CES reveals information about kidney allograft perfusion independent of recipient vascular compliance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25498050     DOI: 10.1016/j.transproceed.2014.04.013

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

Review 1.  New Ultrasound Techniques Promise Further Advances in AKI and CKD.

Authors:  Travis D Hull; Anupam Agarwal; Kenneth Hoyt
Journal:  J Am Soc Nephrol       Date:  2017-09-18       Impact factor: 10.121

2.  Repeatability of Contrast-Enhanced Ultrasound to Determine Renal Cortical Perfusion.

Authors:  Shatha J Almushayt; Alisa Pham; Bethan E Phillips; John P Williams; Maarten W Taal; Nicholas M Selby
Journal:  Diagnostics (Basel)       Date:  2022-05-23

Review 3.  Contrast-enhanced ultrasound of transplant organs - liver and kidney - in children.

Authors:  Doris Franke; Reza J Daugherty; Damjana Ključevšek; Aikaterini Ntoulia; Vasileios Rafailidis; Marcelo S Takahashi; Alvaro Torres; Bernarda Viteri; Frank M Volberg
Journal:  Pediatr Radiol       Date:  2021-05-12

4.  Repeatability of the "flash-replenishment" method in contrast-enhanced ultrasound for the quantitative assessment of hepatic microvascular perfusion.

Authors:  Fang Xie; Wen-Bo Wan; Xiang Fei; Ming-Bo Zhang; Yan Zhang; Hong-Wei Wang; Jie Tang; Wen-Bo Tang; Yu-Kun Luo
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590

Review 5.  Current status of imaging diagnosis in the transplanted kidney. A review of the literature with a special focus on contrast-enhanced ultrasonography.

Authors:  Maria Ramona Bădulescu; Mihai Adrian Socaciu; Tudor Moisoiu; Alexandra Andries; Gheorghiţă Iacob; Radu Badea
Journal:  Med Pharm Rep       Date:  2020-04-22

Review 6.  When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation?

Authors:  Markus Zeisbrich; Lars P Kihm; Felix Drüschler; Martin Zeier; Vedat Schwenger
Journal:  Clin Kidney J       Date:  2015-08-08

Review 7.  Evaluation of kidney allograft status using novel ultrasonic technologies.

Authors:  Cheng Yang; Mushuang Hu; Tongyu Zhu; Wanyuan He
Journal:  Asian J Urol       Date:  2015-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.